Drugs / Indium-DTPA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02947126 Background | Jan 2017 → Feb 2020 | cystic fibrosis | Tim Corcoran | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Indium-DTPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02947126 ↗ |
| Route | Inhaled | “Inhaled Indium 111 DTPA” NCT02947126 ↗ |